The Indian Council of Medical Research (ICMR) successfully organized its 1st Annual Clinical Trial Meet 2026 on May 20, 2026, under the theme “International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials,” marking a significant milestone for India’s clinical research ecosystem. The event featured groundbreaking findings from ICMR’s multicentric Phase III trial on iron deficiency anemia, showing Ayurvedic formulations were therapeutically equivalent to standard iron-folic acid therapy in nearly 4,000 non-pregnant women.
ICMR launched two major reports: “Advancing First-in-Human Phase 1 Clinical Trials in India” and “Operational Guidelines for Single Ethics Review of Multicentre Research” to strengthen regulatory pathways and harmonize ethical reviews nationwide. India’s New Drugs and Clinical Trials (Amendment) Rules 2026 reduced approval timelines from 90 to 45 working days, significantly improving ease of doing business for pharmaceutical companies.
The 17th Annual Clinical Trials Summit 2026 is scheduled for June 10–11 at World Trade Center Mumbai, serving as India’s premier platform for exploring decentralized trials, AI-driven research, and future advancements in clinical trials.
International Updates
The United Kingdom implemented its most significant clinical trials reform in two decades on April 28, 2026, with The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 creating streamlined approvals through a codified Combined Review process. The reforms emphasize risk-proportionate approaches, expedited pathways for low-risk trials, and renewed focus on patient diversity and inclusion.
Global Clinical Trials Connect 2026 will convene leading experts focusing on adaptive trial designs, AI-powered analytics, and patient-centric research strategies, bringing together global leaders, clinical researchers, and technology pioneers. Euro Clinical Trials 2026 is scheduled for June 29–30, 2026 in London, UK, fostering collaboration among international clinical research experts.
International Clinical Trials Day was celebrated on May 20, 2026 worldwide with the theme “Stronger Together: Advanced Therapy Clinical Trials Without Borders,” emphasizing multinational clinical research collaboration and patient-centric approaches
The Clinical and Research Updates section monitors drug and clinical across India's pharmaceutical sector. Significant developments around study continue to draw attention from regulators, investors, and industry professionals, reflecting the dynamic pace of change in this space.
Recent coverage has drawn from CT Mirror, Bioengineer.org, and InsuranceNewsNet, among other publications. This section is updated as new stories emerge, ensuring readers have access to the most current information shaping this part of the pharmaceutical landscape.
For authoritative reference, ClinicalTrials.gov and ICMR Clinical Research publish official guidance and regulatory documentation relevant to these topics. Peer-reviewed research and clinical data can be accessed through NIH Research Portfolio.
Showing 30 articles
-
Opinion: What we could gain from Cuba
Opinion: What we could gain from Cuba CT Mirror
-
AI-enabled clinical trials
AI-enabled clinical trials Bioengineer.org
-
Investigators at Emory University School of Medicine Zero in on Medical Education (Disability prevalence, disclosure, and accommodation use in pediatric residency: results from a pilot study): Education – Medical Education
Investigators at Emory University School of Medicine Zero in on Medical Education (Disability prevalence, disclosure, and accommodation use in pediatric residency: results from a pilot study): Education – Medical Education InsuranceNewsNet
-
Ministry Approves Risky COVID-19 Trial, Falls Short of 1960s FDA Standards
Ministry Approves Risky COVID-19 Trial, Falls Short of 1960s FDA Standards 조선일보
-
Video mental health care may have clinical advantages versus phone or in-person visits
Video mental health care may have clinical advantages versus phone or in-person visits 2 Minute Medicine
-
[Health Talk] Kangbuk Samsung Hospital uses metabolic index changes to predict diabetes risk in younger adults
[Health Talk] Kangbuk Samsung Hospital uses metabolic index changes to predict diabetes risk in younger adults dongascience.com
-
Smarter decisions at scale: How Novartis is using AI to advance R&D
Smarter decisions at scale: How Novartis is using AI to advance R&D Novartis
-
Immutep (IMMP) retools lead cancer drug after trial halt, with next studies years away
Immutep (IMMP) retools lead cancer drug after trial halt, with next studies years away Stock Titan
-
Semaglutide may protect against psychiatric disorders independent of weight loss
Semaglutide may protect against psychiatric disorders independent of weight loss PsyPost
-
Arthritis Drug Restores Up to 100% of Hair in Patients With Severe Alopecia
Arthritis Drug Restores Up to 100% of Hair in Patients With Severe Alopecia Yahoo Health
-
CU Anschutz Advances Precision Medicine for Rare Cancers
CU Anschutz Advances Precision Medicine for Rare Cancers Mirage News
-
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity manilatimes.net
-
Sep 11, 2026 This Week in Cardiology Podcast
Sep 11, 2026 This Week in Cardiology Podcast Medscape
-
Patients Already in Biohaven Epilepsy Trials Keep Dosing as FDA Pauses New Enrollment Over a Rodent Finding
Patients Already in Biohaven Epilepsy Trials Keep Dosing as FDA Pauses New Enrollment Over a Rodent Finding inkl
-
The Cat Health Company Reports Positive Clinical Results in Geriatric Feline Study
The Cat Health Company Reports Positive Clinical Results in Geriatric Feline Study Pet Age
-
Lung Fibrosis Drug Lowers Biological Age Estimates
Lung Fibrosis Drug Lowers Biological Age Estimates Lifespan Research Institute
-
Freedom Broker expects a correction in the U.S. biotech sector
Freedom Broker expects a correction in the U.S. biotech sector Freedom Broker
-
First-in-human study attacks inoperable pancreatic tumors with laser light
First-in-human study attacks inoperable pancreatic tumors with laser light Medical Xpress
-
How Did a Heart Drug With So Much Promise Fall So Flat?
How Did a Heart Drug With So Much Promise Fall So Flat? The New York Times
-
Lung cancer: Drug approved by FDA for pancreatic cancer may help
Lung cancer: Drug approved by FDA for pancreatic cancer may help Medical News Today
-
Weight loss injection semaglutide can reduce asthma attacks by up to 40 per cent, suggests study
Weight loss injection semaglutide can reduce asthma attacks by up to 40 per cent, suggests study medicaldialogues.in
-
Eloxx doses first patients in exaluren Alport trial
Eloxx doses first patients in exaluren Alport trial grafa.com
-
Psilocybin may help prevent chemo-induced nerve pain; Definium scores second FDA Breakthrough Therapy designation
Psilocybin may help prevent chemo-induced nerve pain; Definium scores second FDA Breakthrough Therapy designation The Microdose | Substack
-
$35 Billion Frog Drug Deal Explained: The Psychedelic Treatment That Could Change Depression Therapy
$35 Billion Frog Drug Deal Explained: The Psychedelic Treatment That Could Change Depression Therapy Vocal
-
AbbVie's Atogepant Meets Goal in Late-Stage Menstrual Migraine Study
AbbVie's Atogepant Meets Goal in Late-Stage Menstrual Migraine Study TradingView
-
Cancer Drug Tested Against Hidden HIV Cells
Cancer Drug Tested Against Hidden HIV Cells Legal Reader
-
Smoking linked to lower Parkinson's risk: What's the explanation?
Smoking linked to lower Parkinson's risk: What's the explanation? Medical News Today
-
Novartis shareholders step up scrutiny of deal strategy after del-desiran failure
Novartis shareholders step up scrutiny of deal strategy after del-desiran failure UA.NEWS
-
What’s Standing in the Way of More Diverse Clinical Trials?
What’s Standing in the Way of More Diverse Clinical Trials? Black Doctor
-
Cardiometabolic Risk Factors Can Be Identified in Kids as Young as 8 | Newswise
Cardiometabolic Risk Factors Can Be Identified in Kids as Young as 8 | Newswise Newswise